KAT2B and cholangiocarcinoma: To further validate the downregulation of KAT2B in CCA, we performed additional analyses to compare the expression of KAT2B mRNA between human CCA tissues and non-cancerous bile ducts using the datasets containing BEC gene expression data (GSE26566, GSE32225).